P84. Predicting ASD surgeries that exceed Medicare allowable payment thresholds: a comparison of hospital costs to what the government will actually pay
Jeffrey L. Gum, MD1; Miquel Serra-Burriel, PhD2; Breton Line, BS3; Themistocles S. Protopsaltis, MD4; Alexandra Soroceanu, MD, MPH5; Richard A. Hostin Jr., MD6; Peter G. Passias, MD7; Michael P. Kelly, MD8; Douglas C. Burton, MD9; Justin S. Smith, MD, PhD10; Christopher I. Shaffrey, MD11; Virginie Lafage, PhD12; Eric O. Klineberg, MD13; Han Jo Kim, MD12; Andrew B. Harris, BS14; Khaled M. Kebaish, MD15; Frank J. Schwab, MD12; Shay Bess, MD16; Christopher P. Ames, MD17; International Spine Study Group18
1Norton Leatherman Spine Center, Louisville, KY, US; 2Barcelona, Spain; 3Denver International Spine Center, Denver, CO, US; 4Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 5University of Calgary, Calgary, Canada; 6Southwest Scoliosis Institute, Plano, TX, US; 7NY Spine Institute, NYU Langone Health, New York, NY, US; 8Washington University, Saint Louis, MO, US; 9University of Kansas Medical Center, Kansas City, KS, US; 10UVA Health System, Charlottesville, VA, US; 11University of Virginia, Charlottesville, VA, US; 12Hospital for Special Surgery, New York, NY, US; 13UC, Davis School of Medicine, Sacramento, CA, US; 14Johns Hopkins Hospital, Baltimore, MD, US; 15Johns Hopkins University, Baltimore, MD, US; 16Denver, CO, US; 17University of California, San Francisco, San Francisco, CA, US; 18Brighton, CO, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P85. Objective realignment guidelines in corrective ASD surgery accounting for reciprocal truncal and pelvic compensation
Renaud Lafage, MSc1; Frank J. Schwab, MD1; Jonathan Elysee1; Justin S. Smith, MD, PhD2; Peter G. Passias, MD3; Eric O. Klineberg, MD4; Han Jo Kim, MD1; Christopher I. Shaffrey, MD5; Douglas C. Burton, MD6; Munish C. Gupta, MD7; Gregory M. Mundis Jr., MD8; Christopher P. Ames, MD9; Shay Bess, MD10; Virginie Lafage, PhD1; International Spine Study Group11
1Hospital for Special Surgery, New York, NY, US; 2UVA Health System, Charlottesville, VA, US; 3NY Spine Institute, NYU Langone Health, New York, NY, US; 4UC, Davis School of Medicine, Sacramento, CA, US; 5University of Virginia, Charlottesville, VA, US; 6University of Kansas Medical Center, Kansas City, KS, US; 7Washington University School of Medicine, St. Louis, MO, US; 8Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 9University of California, San Francisco, San Francisco, CA, US; 10Denver, CO, US; 11Brighton, CO, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P86. Patients with high preoperative activity are still satisfied at two-years following ASD surgery despite the potential for postoperative functional decline
Brian J. Neuman, MD1; Andrew B. Harris, BS2; Richard A. Hostin Jr., MD3; Micheal Raad, MD1; Christopher P. Ames, MD4; Themistocles S. Protopsaltis, MD5; Peter G. Passias, MD6; Jeffrey L. Gum, MD7; Alan H. Daniels, MD8; Michael P. Kelly, MD9; Christopher I. Shaffrey, MD10; Douglas C. Burton, MD11; Han Jo Kim, MD12; Khaled M. Kebaish, MD13; International Spine Study Group14
1Baltimore, MD, US; 2Johns Hopkins Hospital, Baltimore, MD, US; 3Southwest Scoliosis Institute, Plano, TX, US; 4University of California, San Francisco, San Francisco, CA, US; 5Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 6NY Spine Institute, NYU Langone Health, New York, NY, US; 7Norton Leatherman Spine Center, Louisville, KY, US; 8Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 9Washington University, Saint Louis, MO, US; 10University of Virginia, Charlottesville, VA, US; 11University of Kansas Medical Center, Kansas City, KS, US; 12Hospital for Special Surgery, New York, NY, US; 13Johns Hopkins University, Baltimore, MD, US; 14Brighton, CO, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.